Recent Advances in In Vivo Somatic Cell Gene Modification in Newborn Pups
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242015301 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Shingo Nakamura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biomedical Engineering, National Defense Medical College Research Institute, Tokorozawa 359-8513, Japan. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Science, Sports, and Culture, Japan.
Abstract (Originalsprache)
Germline manipulation at the zygote stage using the CRISPR/Cas9 system has been extensively employed for creating genetically modified animals and maintaining established lines. However, this approach requires a long and laborious task. Recently, many researchers have attempted to overcome these limitations by generating somatic mutations in the adult stage through tail vein injection or local administration of CRISPR reagents, as a new strategy called “in vivo somatic cell genome editing”. This approach does not require manipulation of early embryos or strain maintenance, and it can test the results of genome editing in a short period. The newborn is an ideal stage to perform in vivo somatic cell genome editing because it is immune-privileged, easily accessible, and only a small amount of CRISPR reagents is required to achieve somatic cell genome editing throughout the entire body, owing to its small size. In this review, we summarize in vivo genome engineering strategies that have been successfully demonstrated in newborns. We also report successful in vivo genome editing through the neonatal introduction of genome editing reagents into various sites in newborns (as exemplified by intravenous injection via the facial vein), which will be helpful for creating models for genetic diseases or treating many genetic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Biomedical Engineering, National Defense Medical College Research Institute, Tokorozawa 359-8513, Japan.
- Department of Pediatric Dentistry, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan.
- Graduate School of Public Health, Shizuoka Graduate University of Public Health, Aoi-ku, Shizuoka 420-0881, Japan.
- Institute of Livestock and Grassland Science, NARO, Tsukuba 305-0901, Japan.
- Department of Pediatric Dentistry, Asahi University School of Dentistry, Mizuho 501-0296, Japan.
- Department of Genome Medicine, National Center for Child Health and Development, Setagaya-ku, Tokyo 157-8535, Japan.
ORCID-Profile: Shingo Nakamura, Issei Saitoh, Masahiro Sato
Förderung
- Ministry of Education, Science, Sports, and Culture, Japan
Zitieren
APA
Nakamura, S., Morohoshi, K., Inada, E., Sato, Y., Watanabe, S., Saitoh, I., & Sato, M. (2023). Recent Advances in In Vivo Somatic Cell Gene Modification in Newborn Pups. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242015301
Vancouver
Nakamura S, Morohoshi K, Inada E, Sato Y, Watanabe S, Saitoh I, et al. Recent Advances in In Vivo Somatic Cell Gene Modification in Newborn Pups. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242015301
BibTeX
@article{Nakamura2023,
author = {Nakamura, Shingo and Morohoshi, Kazunori and Inada, Emi and Sato, Yoko and Watanabe, Satoshi and Saitoh, Issei and Sato, Masahiro},
title = {Recent Advances in In Vivo Somatic Cell Gene Modification in Newborn Pups},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242015301}
}
EUVIMED